Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Self-Reported Prostate Cancer Screening by Race/Ethnicity, New Jersey, 2012 to 2020

Indicator Report Data View Options

  • NAData not available

Why Is This Important?

Prostate cancer is the most commonly occurring form of cancer (excluding skin cancer) among men and is the second leading cause of cancer death for men in New Jersey and the U.S. All men over 40 should visit their doctor for a routine health visit which may include a discussion on prostate health.

Definition

The percentage of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.

Data Notes

  • Data have been age-adjusted to the U.S. 2000 standard population.
  • No data were collected in 2019.

Data Source

Behavioral Risk Factor Survey, Center for Health Statistics, New Jersey Department of Health
(http://www.nj.gov/health/chs/njbrfs/)

How the Measure is Calculated

  • Numerator:

    The number of men aged 40 and above who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider.

  • Denominator:

    The total number of male survey respondents aged 40 or older excluding those who responded "don't know" or "refused" to the numerator question.

Data Issues

Data from the New Jersey Behavioral Risk Factor Survey are intended to be representative of all non-institutionalized adult residents of New Jersey. Due to resource issues, however, adults with limited personal access to phone service or limited command of either English or Spanish are not represented. As with all surveys, also, some error results from nonresponse (e.g., refusal to participate in the survey or to answer specific questions), and faulty measurement (e.g., responses affected by social desirability or recall error). Data collection procedures intended to minimize such errors include the use of strict calling protocols, good questionnaire design, standardization of interviewer behavior, interviewer training, and frequent, on-site interviewer monitoring and supervision. Statistical weighting procedures are also used to minimize the potential impact of disproportionate representation of demographic subgroups defined in terms of age, sex, race, ethnicity, education level, marital status, home ownership, and county of residence. (See also [[a href="query/BRFSSQueryTechNotes.html" Behavioral Risk Factor Survey Data Description and Technical Notes]].)

Related Health Objectives and Indicators


  • Health Initiative: HP2020

    Healthy People 2020 Objective C-19

    U.S. Target: Increase the proportion of men aged 40 years and over who have discussed with their health care provider whether or not to have a prostate-specific antigen (PSA) test to screen for prostate cancer to 15.9 percent by 2020.0
    https://www.healthypeople.gov/2020/topics-objectives/topic/cancer


  • Health Initiative: HNJ2020

    Healthy NJ 2020 Objective CA-17

    NJ Target: Increase the proportion of men aged 40 and over who have discussed the advantages and disadvantages of the prostate-specific antigen (PSA) test to screen for prostate cancer with their health care provider to 24.4 percent (age-adjusted) for the total population, 16.0% for Asians, 38.3% for Blacks, 24.3% for Hispanics, and 22.9% for Whites by 2020.0
    https://www.nj.gov/health/chs/hnj2020/topics/cancer.shtml


Health Care System Factors

See [https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening] for prostate cancer screening recommendations.

Related Health Status Outcomes Indicators:

Health Topic Pages Related to: Self-Reported Prostate Cancer Screening

Indicator Data Last Updated On 09/25/2023, Published on 03/06/2025
Center for Health Statistics, New Jersey Department of Health, PO Box 360, Trenton, NJ 08625-0360, e-mail: chs@doh.nj.gov (https://www.nj.gov/health/chs)